Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Norm Evans, Chief Financial Officer, is presenting at the 2014 Bloom Burton & Co. Healthcare Investor...

Cipher Pharmaceuticals Inc. (TSX: DND) ("the Company"), in accordance with Toronto Stock Exchange requirements, announced the voting results from its Annual General Meeting of Shareholders held...

Company achieves ninth consecutive quarter of profitability Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 2, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced it will host a conference call for its Q1 2014 financial results and hold its Annual General Meeting of...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Thomas G. Wellner has been appointed to the Board of Directors of the Company. Most recently, Mr. Wellner...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Larry Andrews will be stepping down from his position as President and Chief Executive Officer. To ensure a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and twelve months ended December 31, 2013. Fiscal 2013 Highlights Total revenue of $27.0...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q4 and Year-End 2013 financial results on Wednesday, February 26, 2014. Q4 and Year-End...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Gerald (Gerry) McDole has been appointed as Chair of the Board of Directors of the Company effective...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that its marketing partner for Absoricaä has reached a cumulative sales milestone in accordance with the...